Your browser doesn't support javascript.
loading
A phase 1 study of buparlisib and bevacizumab in patients with metastatic renal cell carcinoma progressing on vascular endothelial growth factor-targeted therapies.
McKay, Rana R; De Velasco, Guillermo; Werner, Lillian; Bellmunt, Joaquim; Harshman, Lauren; Sweeney, Christopher; Rosenberg, Jonathan E; Hirsch, Michelle; Signoretti, Sabina; Van Allen, Eliezer M; Walsh, Meghara; Vaishampayan, Ulka; McDermott, David F; Choueiri, Toni K.
Afiliação
  • McKay RR; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • De Velasco G; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Werner L; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Bellmunt J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Harshman L; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Sweeney C; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Rosenberg JE; Deparment of Medical Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Hirsch M; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.
  • Signoretti S; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.
  • Van Allen EM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Walsh M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Vaishampayan U; Department of Hematology/Oncology, Karmanos Cancer Institute, Wayne State University, Detroit, Michigan.
  • McDermott DF; Department of Medical Oncology, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
  • Choueiri TK; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
Cancer ; 122(15): 2389-98, 2016 Aug 01.
Article em En | MEDLINE | ID: mdl-27198170

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias Renais Tipo de estudo: Clinical_trials Limite: Female / Humans / Male Idioma: En Revista: Cancer Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias Renais Tipo de estudo: Clinical_trials Limite: Female / Humans / Male Idioma: En Revista: Cancer Ano de publicação: 2016 Tipo de documento: Article